v3.26.1
ACQUISITIONS
 6 Months Ended
Jun. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
ACQUISITIONS ACQUISITIONS
During the six months ended June 30, 2026, we used $130 million of cash for acquisition-related activity, of which $128 million related to acquisitions and consolidations completed during that period and $2 million related to measurement‑period adjustments for acquisitions completed during 2025. During the six months ended June 30, 2025, we used $147 million of cash for acquisition‑related activity, of which $138 million related to acquisitions and consolidations completed during that period and $9 million related to measurement‑period adjustments for acquisitions completed during 2024.
We are required to allocate the purchase prices of acquired businesses to assets acquired or liabilities assumed and, if applicable, noncontrolling interests based on their fair values. The excess of the purchase prices allocated over those fair values is recorded as goodwill. The purchase price allocations for certain acquisitions completed in 2026 and 2025 are preliminary. We are in the process of assessing working capital balances and lease and other agreements assumed, as well as obtaining and evaluating valuations of the acquired property and equipment, management contracts and other intangible assets, and noncontrolling interests. Therefore, those purchase price allocations, including goodwill, recorded in the accompanying Condensed Consolidated Financial Statements are subject to adjustment once the assessments and valuation work are completed and evaluated. Such adjustments will be recorded as soon as practical and within the measurement period as defined by the accounting literature. During the six months ended June 30, 2026, we adjusted the preliminary purchase price allocations of certain Ambulatory Care segment acquisitions completed in 2025 based on the results of completed valuations and post‑closing working capital adjustments. These adjustments resulted in an increase of $5 million in goodwill recognized.
The table below presents the preliminary or final purchase price allocations for acquisitions made during the six months ended June 30, 2026 and 2025:
Six Months Ended June 30,
20262025
Current assets$22 $35 
Property and equipment20 22 
Other intangible assets3 5 
Goodwill237 255 
Long-term operating lease assets15 73 
Other long-term assets3 — 
Previously held investments in unconsolidated affiliates3 (70)
Current liabilities(8)(35)
Long-term operating lease liabilities(15)(69)
Other long-term liabilities(18)(6)
Redeemable noncontrolling interests in equity of consolidated subsidiaries(57)(72)
Noncontrolling interests(59)(33)
Cash paid, net of cash acquired(128)(138)
Gains (losses) on consolidations$18 $(33)
The goodwill generated from our 2026 acquisitions, the majority of which we believe will not be deductible for income tax purposes, can be attributed to the benefits that we expect to realize from operating efficiencies and growth strategies. Goodwill recognized related to our acquisition activity during the six months ended June 30, 2026 was entirely attributable to our Ambulatory Care segment.